Skip to main content

$0.007 (0.00%)










30 June 2023 at 4:10pm
Register to track ME1 and receive email alerts.

Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser. In addition, the company develops Halucenex, which is in phase II clinical trials, which will test the efficacy of psilocybin on treatment of resistant Post Traumatic Stress Disorder. Further, it engages in marketing of its hemp based food, feed supplements, and topical products; manufacture and sale of packaged consumer products; conducts clinical trial and development of synthetic psilocybin micro and macro dose formulations to treat treatment resistant depression and anxiety; and development of psychedelic medicines. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Expand Company Description

Market Cap (19-Apr)

$1,127,480 (0th)

Close (30-Jun)


Volume (30-Jun)


Shortsold (12-Apr)

17,723 (0.00%) (582nd)

52w High


52w Low






Appendix 2A


416,823 posts

ME1 released this announcement to the ASX on 21 June 2023, 19:14. The announcement is not marked as price sensitive, and is 19 page(s) in length and 350.19kb in size.

You can view all announcements from ME1 and see how they appear on a price chart on the announcements page.

At the date of this announcement, ME1 was 0.062% short sold according to ASIC data. It was ranked the 497th most shorted stock on the ASX. It remains ranked 582nd as of the latest reported data (12 April 2024).

Other Recent Announcements from ME1
Appendix 3G 30 June 2023, 19:03
Appendix 2A 30 June 2023, 19:01
Appendix 2A 26 June 2023, 19:02
Appendix 2A 21 June 2023, 19:14
Change in substantial holding 21 June 2023, 18:16
Appendix 3B - Amendment 19 June 2023, 19:01
Appendix 3B 19 June 2023, 18:59

ME1 was $0.007 at the close of trade on 21 June 2023

You must login or register to post a comment.

You must be logged in to post a reply.

Register to track ME1 and receive email alerts.